SELECTED PHARMACOGENETIC PANEL TEST FOR TOXICITY PREVENTION OF DRUG-DRUG INTERACTIONS BETWEEN HIGHLY ACTIVE ANTIRETROVIRAL THERAPY (HAART) AND ANTIBLASTIC CHEMOTHERAPY